The surgical management of medullary thyroid cancer

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Medullary thyroid cancer (MTC), accounts for approximately 5% to 10% of all thyroid cancers. Significant advances in the understanding of the biology and clinical outcomes of MTC have been made over the last decade, culminating most recently in the publication of treatment guidelines by the American Thyroid Association that follow an evidence-based approach that is summarized in this presentation. Prognosis, genetic testing, surgical technique, and re-operation are also discussed.

Original languageEnglish (US)
Pages (from-to)365-374
Number of pages10
JournalOtolaryngologic Clinics of North America
Volume43
Issue number2
DOIs
StatePublished - Apr 2010

Fingerprint

Genetic Testing
Thyroid Neoplasms
Publications
Guidelines
Medullary Thyroid cancer

Keywords

  • DNA testing
  • Evidence-based treatment
  • Medullary thyroid cancer
  • Prognosis
  • Surgical techniques
  • Thyroidectomy
  • Treatment guidelines

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

The surgical management of medullary thyroid cancer. / Dackiw, Alan P B.

In: Otolaryngologic Clinics of North America, Vol. 43, No. 2, 04.2010, p. 365-374.

Research output: Contribution to journalArticle

@article{824eba0269a6469c8803bb29bbe4bc58,
title = "The surgical management of medullary thyroid cancer",
abstract = "Medullary thyroid cancer (MTC), accounts for approximately 5{\%} to 10{\%} of all thyroid cancers. Significant advances in the understanding of the biology and clinical outcomes of MTC have been made over the last decade, culminating most recently in the publication of treatment guidelines by the American Thyroid Association that follow an evidence-based approach that is summarized in this presentation. Prognosis, genetic testing, surgical technique, and re-operation are also discussed.",
keywords = "DNA testing, Evidence-based treatment, Medullary thyroid cancer, Prognosis, Surgical techniques, Thyroidectomy, Treatment guidelines",
author = "Dackiw, {Alan P B}",
year = "2010",
month = "4",
doi = "10.1016/j.otc.2010.01.006",
language = "English (US)",
volume = "43",
pages = "365--374",
journal = "Otolaryngologic Clinics of North America",
issn = "0030-6665",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - The surgical management of medullary thyroid cancer

AU - Dackiw, Alan P B

PY - 2010/4

Y1 - 2010/4

N2 - Medullary thyroid cancer (MTC), accounts for approximately 5% to 10% of all thyroid cancers. Significant advances in the understanding of the biology and clinical outcomes of MTC have been made over the last decade, culminating most recently in the publication of treatment guidelines by the American Thyroid Association that follow an evidence-based approach that is summarized in this presentation. Prognosis, genetic testing, surgical technique, and re-operation are also discussed.

AB - Medullary thyroid cancer (MTC), accounts for approximately 5% to 10% of all thyroid cancers. Significant advances in the understanding of the biology and clinical outcomes of MTC have been made over the last decade, culminating most recently in the publication of treatment guidelines by the American Thyroid Association that follow an evidence-based approach that is summarized in this presentation. Prognosis, genetic testing, surgical technique, and re-operation are also discussed.

KW - DNA testing

KW - Evidence-based treatment

KW - Medullary thyroid cancer

KW - Prognosis

KW - Surgical techniques

KW - Thyroidectomy

KW - Treatment guidelines

UR - http://www.scopus.com/inward/record.url?scp=77953239940&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953239940&partnerID=8YFLogxK

U2 - 10.1016/j.otc.2010.01.006

DO - 10.1016/j.otc.2010.01.006

M3 - Article

VL - 43

SP - 365

EP - 374

JO - Otolaryngologic Clinics of North America

JF - Otolaryngologic Clinics of North America

SN - 0030-6665

IS - 2

ER -